Business

Ventripoint Announces Date and Webinar Details Regarding First Quarter 2023 Financial Results

(TheNewswire) Toronto, O N - TheNewswire - May 29 , 2023 - Ventripo...

articleVentripoint Diagnostics Ltd.May 29, 20234/company/ventripoint-diagnostics-ltd/news/ventripoint-announces-date-and-webinar-details-regarding-first-quarter-2023-financial-results
Ventripoint Announces Date and Webinar Details Regarding First Quarter 2023 Financial Results

About this update from Ventripoint Diagnostics Ltd.

[{"type":"text","content":"Ventripoint Announces Date and Webinar Details Regarding First Quarter 2023 Financial Results \n \n \n (TheNewswire)\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Toronto, O\n \n \n N\n \n \n -\n \n \n TheNewswire - May\n \n \n 29\n \n \n , 2023 -\n \n \n Ventripoint\nDiagnostics Ltd. (\"\n \n \n Ventripoint\n \n \n \" or the \"\n \n \n Company\n \n \n \"),\n \n \n (TSXV:VPT\n \n \n )\n \n \n (\n \n \n OTC:VPTDF)\n \n \n is pleased to announce that it will release its\nfirst-quarter, unaudited financial results for 2023 on Tuesday, May\n30, 2023 at close of market.\n \n \n \n \n Ventripoint will hold a webinar/conference call at\n10:00 a.m. (EST) on Thursday, June 1, 2023, to discuss its Q1 2023\nfinancial results and to provide an update on sales and marketing\nactivities of Q1.\n \n \n \n \n Details of the webinar/conference call are as follows:\n \n \n \n \n \n \n \n PARTICIPANT TELEPHONE NUMBERS\n \n \n \n \n \n \n \n \n Participant Link:\n \n \n \n \n https://www.c-meeting.com/web3/joinTo/3WYDHYDEHKKUTR/tDFG0JqDdVD3E40GGed85w\n \n \n \n \n \n \n \n \n \n \n Alternatively, if participant does\nnot have Internet, please call:\n \n \n \n \n \n \n \n \n Canada/US Toll Free:\n1-844-763-8274\n \n \n \n \n \n \n \n \n International Toll:\n+1-647-484-8814\n \n \n \n \n \n \n \n \n \n \n \n To ensure your participation, please dial in 5 – 10\nminutes prior to the scheduled start time and simply ask to join the\ncall.\n \n \n \n \n About Ventripoint Diagnostics\nLtd.\n \n \n \n \n Ventripoint\n \n \n has become an\nindustry leader in the application of AI (Artificial Intelligence) to\nechocardiography. Ventripoint's VMS products are powered by its\nproprietary KBR technology, which is the result of a decade of\ndevelopment and provides accurate volumetric cardiac measurements\nequivalent to MRI. This affordable, gold-standard alternative allows\ncardiologists greater confidence in the management of their patients.\nProviding better care to patients serves as a springboard and basic\nstandard for all of Ventripoint's products that guide our future\ndevelopments. In addition, VMS+ is versatile and can be used with all\nultrasound systems from any vendor supported by regulatory market\napprovals in the U.S., Europe and Canada.\n \n \n \n \n For\n \n \n further information, please\ncontact:\n \n \n \n \n Jonatha...

More updates from Ventripoint Diagnostics Ltd.